A One-Year PIDTC Research Training Grant in Primary Immunodeficiencies
The purpose of the award is to encourage research in primary immunodeficiencies, particularly related to treatment by, transplantation, gene therapy, or best available medical management. Please send application to Dawn Westerfer at email@example.com
Eligibility: Trainees or Junior Faculty with two years or less as a faculty member. Prior recipients can compete to receive one additional year of continuous funding with a progress report documenting that headway has been made on the research topic as long as they are still eligible by trainee status. Underrepresented minority applicants specifically encouraged to apply.
Format: The three page application should include: Title, Name and Contact Information of Applicant, Name and Contact Information of Mentor for the Project, Aims, Background, and Methods. NIH margins and font sizes should be used.
Components: Three page scientific proposal containing: (i) Title page; (ii) Proposal (3 page limit) and References; (iii) Career development page limited to 150 words on the topic of career aspirations and 150 words discussing the career development activities to be pursued during the time frame of the grant; (iv) NIH Biosketches on application and mentor; (v) Budget and justification, including the effort related to the project and to other commitments; (vi) Letter of support from Division Chief to demonstrate protected time and adequate resources; (vii) Letter of support from primary scientific Mentor discussing planned career development.
References, letters, and budget pages do not count against the 3 page limit.
The application components should be compiled into a single PDF in the order listed and emailed to Dawn Westerfer before March 15, 2021. Notice of awards will be made in the Spring of 2021.
Terms: Applicants must be from USA and Canada. Late applications will not be considered. Funding will provide $25,000 salary/consumables support from September 1, 2021 through August 31, 2022. Indirect costs of and additional 8% are allowed. Awardees will provide a scientific summary upon completion and career updates for 5 years. Attendance at the annual PIDTC meeting is expected and participation in PIDTC protocols is encouraged.
Scoring of applications: A committee will score each application based on the following criteria:
- 40% Scientific merit of proposal
- 30% Quality of candidate and commitment to the field of PID
- 20% Quality of mentor and mentorship program
- 10% Potential impact on the field of Primary Immunodeficiency and the goals of the PIDTC.
Inquiries: Kate Sullivan (firstname.lastname@example.org) or Elie Haddad (email@example.com)